Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug DiscoveryClinical TrialClinical Development

PUBLISHER: Grand View Research | PRODUCT CODE: 1842078

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1842078

Middle East Clinical Trials Market Size, Share & Trends Analysis Report By Phase, By Study Design, By Indication, By Indication By Study Design, By Service, By Sponsor, By Country, And Segment Forecasts, 2025 - 2033

PUBLISHED:
PAGES: 180 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Middle East Clinical Trials Market Summary

The Middle East clinical trials market size was estimated at USD 638.11 million in 2024 and is projected to reach USD 1,169.34 million by 2033, growing at a CAGR of 7.18% from 2025 to 2033. The Middle East faces a rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, obesity, and cancer, creating strong demand for new therapies.

Countries like Saudi Arabia, UAE, and Qatar report some of the world's highest diabetes rates, making them prime locations for trials targeting metabolic and lifestyle-related conditions. According to the Telecommunications and Digital Government Regulatory Authority 2024, as of 2021, diabetes affected 11.8% of the UAE population. Reducing its prevalence remains a key performance indicator under the world-class healthcare pillar of the UAE National Agenda 2021. This growing disease burden drives pharmaceutical companies to establish local clinical studies to test the efficacy of novel drugs on region-specific populations. The urgent need for better therapeutic options also ensures government and healthcare sector support, fueling market expansion in the region.

Middle Eastern governments are prioritizing research and innovation to strengthen healthcare systems and diversify economies. Saudi Arabia's Vision 2030, UAE's Centennial 2071, and Qatar's National Health Strategy all emphasize clinical research, digital health, and partnerships with global pharma firms. Regulatory reforms are streamlining trial approvals, while infrastructure investments expand research centers and trial sites. Setting up clinical trials in the Middle East offers sponsors higher patient recruitment and stronger investigator engagement compared to traditional hubs. Conducting trials in regions with unmet clinical needs enhances access, optimizes efficiency, and supports innovation, especially when combined with AI and real-world data integration for regulatory submissions.

The adoption of reliance models and harmonized regulatory frameworks across the Gulf Cooperation Council (GCC) and Arab Regulators Network is a strong growth driver. Saudi Arabia's SFDA and Qatar's Ministry of Public Health are advancing regulatory reforms to align with global standards through reliance practices, digitalization, and collaboration. Efforts include streamlined approvals, pharmacovigilance, and AI integration. By referencing approvals from trusted agencies like the US FDA, EMA, or regional peers, Middle Eastern regulators accelerate the review and approval of clinical trials and new therapies. This harmonization reduces duplication, shortens approval timelines, and enhances confidence among international sponsors. Combined with digital regulatory platforms and cross-border collaborations, these practices strengthen efficiency and ensure high safety and quality standards, making the Middle East an increasingly attractive destination for global clinical research.

Public-private partnerships further attract foreign investment. For instance, in December 2024, Uncommon Cures partnered with UAE-based Carexso and PDC FZ LLC to accelerate orphan drug clinical trials in the Middle East. Combining expertise in rare disease drug development with regional infrastructure, this collaboration aimed to streamline regulatory pathways, expand access, and deliver innovative therapies to underserved rare disease patients. This supportive environment encourages both multinational and regional companies to conduct clinical trials, positioning the Middle East as an emerging hub for pharmaceutical innovation and life sciences research.

The Middle East region has seen rapid development in healthcare and research infrastructure, including modern hospitals, advanced laboratories, and specialized research institutes. Leading Contract Research Organizations (CROs) and local clinical research units are expanding operations in countries such as Saudi Arabia, the UAE, and Egypt, bringing global expertise and technology. The availability of electronic health records, biobanks, and genomic research initiatives further enhances trial efficiency. This robust infrastructure supports complex trials, from Phase I to Phase IV, while ensuring compliance with international standards. As a result, more pharmaceutical companies are choosing the Middle East for high-quality, large-scale clinical studies.

Middle East Clinical Trials Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Middle East clinical trials market report based on phase, study design, indication, indication by study design, service, sponsor, and country:

  • Phase Outlook (Revenue, USD Million, 2021 - 2033)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Study Design Outlook (Revenue, USD Million, 2021 - 2033)
  • Interventional Trials
  • Observational Trials
  • Expanded Access Trials
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Autoimmune/Inflammation
    • Rheumatoid Arthritis
    • Multiple Sclerosis
    • Osteoarthritis
    • Irritable Bowel Syndrome (IBS)
    • Others
  • Pain Management
    • Chronic Pain
    • Acute Pain
  • Oncology
    • Blood Cancer
    • Solid Tumors
    • Others
  • CNS Conditions
    • Epilepsy
    • Parkinson's Disease (PD)
    • Huntington's Disease
    • Stroke
    • Traumatic Brain Injury (TBI)
    • Amyotrophic Lateral Sclerosis (ALS)
    • Muscle Regeneration
    • Others
  • Diabetes
  • Obesity
  • Cardiovascular Diseases
  • Others
  • Indication by Study Design Outlook (Revenue, USD Million, 2021 - 2033)
  • Autoimmune/Inflammation
    • Interventional Trials
    • Observational Trials
    • Expanded Access Trials
  • Pain Management
    • Interventional Trials
    • Observational Trials
    • Expanded Access Trials
  • Oncology
    • Interventional Trials
    • Observational Trials
    • Expanded Access Trials
  • CNS Conditions
    • Interventional Trials
    • Observational Trials
    • Expanded Access Trials
  • Diabetes
    • Interventional Trials
    • Observational Trials
    • Expanded Access Trials
  • Obesity
    • Interventional Trials
    • Observational Trials
    • Expanded Access Trials
  • Cardiovascular Diseases
    • Interventional Trials
    • Observational Trials
    • Expanded Access Trials
  • Others
    • Interventional Trials
    • Observational Trials
    • Expanded Access Trials
  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Protocol Designing
  • Site Identification
  • Patient Recruitment
  • Laboratory Services
  • Analytical Testing Services
  • Clinical Trial Data Management Services
  • Others
  • Sponsor Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biopharmaceutical Companies
  • Medical Device Companies
  • Others
  • Country Outlook (Revenue, USD Million, 2021 - 2033)
  • Middle East
    • Saudi Arabia
    • UAE
    • Kuwait
    • Oman
    • Qatar
Show more
Product Code: GVR-4-68040-729-0

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Value chain based analysis (Model 2)
    • 1.7.3. Multivariate Analysis (Model 3)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Middle East Clinical Trials Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Market Challenge Analysis
  • 3.3. R&D Spending Analysis
    • 3.3.1. R&D Investment Analysis, by Key Sponsors (2021-2024)
    • 3.3.2. Venture Capital & Government Funding Scenario
  • 3.4. Middle East Clinical Trials Design Analysis
  • 3.5. Industry Ecosystem Analysis
  • 3.6. Technology Landscape
  • 3.7. Clinical Trial Volume Analysis, 2024
    • 3.7.1. Total Number of Middle East Clinical Trials, By Region (2024)
    • 3.7.2. Total Number of Middle East Clinical Trials, By Phase (2024)
    • 3.7.3. Total Number of Middle East Clinical Trials, By Study Design (2024)
    • 3.7.4. Total Number of Middle East Clinical Trials, By Key Indication (2024)
  • 3.8. Middle East Clinical Trials Market Analysis Tools
    • 3.8.1. Porter's Five Forces Analysis
    • 3.8.2. PESTEL by SWOT Analysis

Chapter 4. Middle East Clinical Trials Market: Phase Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Middle East Clinical Trials Market: Phase Movement Analysis
  • 4.3. Middle East Clinical Trials Market Estimates and Forecasts, by Phase, 2021 - 2033 (USD Million)
  • 4.4. Phase I
    • 4.4.1. Phase I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Phase II
    • 4.5.1. Phase II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Phase III
    • 4.6.1. Phase III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Phase IV
    • 4.7.1. Phase IV Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Middle East Clinical Trials Market: Study Design Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Middle East Clinical Trials Market: Study Design Movement Analysis
  • 5.3. Middle East Clinical Trials Market Estimates and Forecasts, by Study Design, 2021 - 2033 (USD Million)
  • 5.4. Interventional trials
    • 5.4.1. Interventional Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Observational trials
    • 5.5.1. Observational Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Expanded Access trials
    • 5.6.1. Expanded Access Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Middle East Clinical Trials Market: Indication Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Middle East Clinical Trials Market: Indication Movement Analysis
  • 6.3. Middle East Clinical Trials Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
  • 6.4. Autoimmune/Inflammation
    • 6.4.1. Autoimmune/Inflammation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. Rheumatoid Arthritis
      • 6.4.2.1. Rheumatoid Arthritis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Multiple Sclerosis
      • 6.4.3.1. Multiple Sclerosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Osteoarthritis
      • 6.4.4.1. Osteoarthritis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.5. Irritable Bowel Syndrome (IBS)
      • 6.4.5.1. Irritable Bowel Syndrome (IBS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.6. Others
      • 6.4.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Pain Management
    • 6.5.1. Pain Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. Chronic Pain
      • 6.5.2.1. Chronic Pain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Acute Pain
      • 6.5.3.1. Acute Pain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Oncology
    • 6.6.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Blood Cancer
      • 6.6.2.1. Blood Cancer Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. Solid Tumors
      • 6.6.3.1. Solid Tumors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. Others
      • 6.6.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. CNS Conditions
    • 6.7.1. CNS Conditions Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. Epilepsy
      • 6.7.2.1. Epilepsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Parkinson's Disease (PD)
      • 6.7.3.1. Parkinson's Disease (PD) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.4. Huntington's Disease
      • 6.7.4.1. Huntington's Disease Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.5. Stroke
      • 6.7.5.1. Stroke Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.6. Traumatic Brain Injury (TBI)
      • 6.7.6.1. Traumatic Brain Injury (TBI) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.7. Amyotrophic Lateral Sclerosis (ALS)
      • 6.7.7.1. Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.8. Muscle Regeneration
      • 6.7.8.1. Muscle Regeneration Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.9. Others
      • 6.7.9.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Diabetes
    • 6.8.1. Diabetes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9. Obesity
    • 6.9.1. Obesity Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.10. Cardiovascular Diseases
    • 6.10.1. Cardiovascular Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.11. Others
    • 6.11.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Middle East Clinical Trials Market: Indication by Study Design Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Middle East Clinical Trials Market: Indication by Study Design Movement Analysis
  • 7.3. Middle East Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2021 - 2033 (USD Million)
  • 7.4. Autoimmune/Inflammation
    • 7.4.1. Autoimmune/Inflammation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. Interventional Trials
      • 7.4.2.1. Interventional Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Observational Trials
      • 7.4.3.1. Observational Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. Expanded Access Trials
      • 7.4.4.1. Expanded Access Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Pain Management
    • 7.5.1. Pain Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Interventional Trials
      • 7.5.2.1. Interventional Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Observational Trials
      • 7.5.3.1. Observational Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. Expanded Access Trials
      • 7.5.4.1. Expanded Access Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Oncology
    • 7.6.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Interventional Trials
      • 7.6.2.1. Interventional Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Observational Trials
      • 7.6.3.1. Observational Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. Expanded Access Trials
      • 7.6.4.1. Expanded Access Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. CNS Conditions
    • 7.7.1. CNS Conditions Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Interventional Trials
      • 7.7.2.1. Interventional Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Observational Trials
      • 7.7.3.1. Observational Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. Expanded Access Trials
      • 7.7.4.1. Expanded Access Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Diabetes
    • 7.8.1. Diabetes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. Interventional Trials
      • 7.8.2.1. Interventional Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Observational Trials
      • 7.8.3.1. Observational Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. Expanded Access Trials
      • 7.8.4.1. Expanded Access Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.9. Obesity
    • 7.9.1. Obesity Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.9.2. Interventional Trials
      • 7.9.2.1. Interventional Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.9.3. Observational Trials
      • 7.9.3.1. Observational Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.9.4. Expanded Access Trials
      • 7.9.4.1. Expanded Access Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.10. Cardiovascular Diseases
    • 7.10.1. Cardiovascular Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.10.2. Interventional Trials
      • 7.10.2.1. Interventional Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.10.3. Observational Trials
      • 7.10.3.1. Observational Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.10.4. Expanded Access Trials
      • 7.10.4.1. Expanded Access Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.11. Others
    • 7.11.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.11.2. Interventional Trials
      • 7.11.2.1. Interventional Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.11.3. Observational Trials
      • 7.11.3.1. Observational Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.11.4. Expanded Access Trials
      • 7.11.4.1. Expanded Access Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Middle East Clinical Trials Market: Service Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Middle East Clinical Trials Market: Service Movement Analysis
  • 8.3. Middle East Clinical Trials Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • 8.4. Protocol Designing
    • 8.4.1. Protocol Designing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Site Identification
    • 8.5.1. Site Identification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Patient Recruitment
    • 8.6.1. Patient Recruitment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Laboratory Services
    • 8.7.1. Laboratory Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8. Analytical Testing Services
    • 8.8.1. Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.9. Clinical Trial Data Management Services
    • 8.9.1. Clinical Trial Data Management Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.10. Others
    • 8.10.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Middle East Clinical Trials Market: Sponsor Estimates & Trend Analysis

  • 9.1. Segment Dashboard
  • 9.2. Middle East Clinical Trials Market: Sponsor Movement Analysis
  • 9.3. Middle East Clinical Trials Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • 9.4. Pharmaceutical & Biopharmaceutical Companies
    • 9.4.1. Pharmaceutical & Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5. Medical Device Companies
    • 9.5.1. Medical Device Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6. Others
    • 9.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Middle East Clinical Trials Market: Regional Estimates & Trend Analysis

  • 10.1. Regional Outlook
  • 10.2. Middle East Clinical Trials Market: Regional Movement Analysis
  • 10.3. Middle East Clinical Trials Market Estimates and Forecasts, by region, 2021 - 2033 (USD Million)
    • 10.3.1. Saudi Arabia
      • 10.3.1.1. Key Country Dynamics
      • 10.3.1.2. Competitive Scenario
      • 10.3.1.3. Regulatory Framework
      • 10.3.1.4. Saudi Arabia Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 10.3.2. UAE
      • 10.3.2.1. Key Country Dynamics
      • 10.3.2.2. Competitive Scenario
      • 10.3.2.3. Regulatory Framework
      • 10.3.2.4. UAE Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 10.3.3. Kuwait
      • 10.3.3.1. Key Country Dynamics
      • 10.3.3.2. Competitive Scenario
      • 10.3.3.3. Regulatory Framework
      • 10.3.3.4. Kuwait Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 10.3.4. Oman
      • 10.3.4.1. Key Country Dynamics
      • 10.3.4.2. Competitive Scenario
      • 10.3.4.3. Regulatory Framework
      • 10.3.4.4. Oman Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 10.3.5. Qatar
      • 10.3.5.1. Key Country Dynamics
      • 10.3.5.2. Competitive Scenario
      • 10.3.5.3. Regulatory Framework
      • 10.3.5.4. Qatar Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 11. Competitive Landscape

  • 11.1. Company Categorization
    • 11.1.1. Innovators
    • 11.1.2. Market Leaders
    • 11.1.3. Emerging Players
  • 11.2. Company Market Assessment Analysis, 2024 (Company Heat Map Analysis)
  • 11.3. Key Company Profiles
    • 11.3.1. Sanofi
      • 11.3.1.1. Company Overview
      • 11.3.1.2. Financial Performance
      • 11.3.1.3. Service Benchmarking
      • 11.3.1.4. Strategic Initiatives
    • 11.3.2. Novartis AG
      • 11.3.2.1. Company Overview
      • 11.3.2.2. Financial Performance
      • 11.3.2.3. Service Benchmarking
      • 11.3.2.4. Strategic Initiatives
    • 11.3.3. Pfizer
      • 11.3.3.1. Company Overview
      • 11.3.3.2. Financial Performance
      • 11.3.3.3. Service Benchmarking
      • 11.3.3.4. Strategic Initiatives
    • 11.3.4. GSK plc
      • 11.3.4.1. Company Overview
      • 11.3.4.2. Financial Performance
      • 11.3.4.3. Service Benchmarking
      • 11.3.4.4. Strategic Initiatives
    • 11.3.5. Novo Nordisk A/S
      • 11.3.5.1. Company Overview
      • 11.3.5.2. Financial Performance
      • 11.3.5.3. Service Benchmarking
      • 11.3.5.4. Strategic Initiatives
    • 11.3.6. Hikma Pharmaceuticals PLC
      • 11.3.6.1. Company Overview
      • 11.3.6.2. Financial Performance
      • 11.3.6.3. Service Benchmarking
      • 11.3.6.4. Strategic Initiatives
    • 11.3.7. Julphar
      • 11.3.7.1. Company Overview
      • 11.3.7.2. Financial Performance
      • 11.3.7.3. Service Benchmarking
      • 11.3.7.4. Strategic Initiatives
    • 11.3.8. SPIMACO
      • 11.3.8.1. Company Overview
      • 11.3.8.2. Financial Performance
      • 11.3.8.3. Service Benchmarking
      • 11.3.8.4. Strategic Initiatives
    • 11.3.9. Tabuk Pharmaceuticals
      • 11.3.9.1. Company Overview
      • 11.3.9.2. Financial Performance
      • 11.3.9.3. Service Benchmarking
      • 11.3.9.4. Strategic Initiatives
    • 11.3.10. F. Hoffmann-La Roche Ltd
      • 11.3.10.1. Company Overview
      • 11.3.10.2. Financial Performance
      • 11.3.10.3. Service Benchmarking
      • 11.3.10.4. Strategic Initiatives
    • 11.3.11. Johnson & Johnson
      • 11.3.11.1. Company Overview
      • 11.3.11.2. Financial Performance
      • 11.3.11.3. Service Benchmarking
      • 11.3.11.4. Strategic Initiatives
  • 11.4. List of Other Key Market Players
Show more
Product Code: GVR-4-68040-729-0

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Middle East Clinical Trials Market Estimates and Forecasts, by Phase, 2021 - 2033 (USD Million)
  • Table 4 Middle East Clinical Trials Market Estimates and Forecasts, by Study Design, 2021 - 2033 (USD Million)
  • Table 5 Middle East Clinical Trials Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 6 Middle East Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
  • Table 7 Middle East Clinical Trials Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 8 Middle East Clinical Trials Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 9 Middle East Clinical Trials Market Estimates and Forecasts, by Region, 2021 - 2033 (USD Million)
  • Table 10 UAE Clinical Trials Market Estimates and Forecasts, by Phase, 2021 - 2033 (USD Million)
  • Table 11 UAE Clinical Trials Market Estimates and Forecasts, by Study Design, 2021 - 2033 (USD Million)
  • Table 12 UAE Clinical Trials Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 13 UAE Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
  • Table 14 UAE Clinical Trials Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 15 UAE Clinical Trials Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 16 Saudi Arabia Clinical Trials Market Estimates and Forecasts, by Phase, 2021 - 2033 (USD Million)
  • Table 17 Saudi Arabia Clinical Trials Market Estimates and Forecasts, by Study Design, 2021 - 2033 (USD Million)
  • Table 18 Saudi Arabia Clinical Trials Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 19 Saudi Arabia Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
  • Table 20 Saudi Arabia Clinical Trials Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 21 Saudi Arabia Clinical Trials Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 22 Kuwait Clinical Trials Market Estimates and Forecasts, by Phase, 2021 - 2033 (USD Million)
  • Table 23 Kuwait Clinical Trials Market Estimates and Forecasts, by Study Design, 2021 - 2033 (USD Million)
  • Table 24 Kuwait Clinical Trials Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 25 Kuwait Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
  • Table 26 Kuwait Clinical Trials Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 27 Kuwait Clinical Trials Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 28 Oman Clinical Trials Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 29 Oman Clinical Trials Market Estimates and Forecasts, by Phase, 2021 - 2033 (USD Million)
  • Table 30 Oman Clinical Trials Market Estimates and Forecasts, by Study Design, 2021 - 2033 (USD Million)
  • Table 31 Oman Clinical Trials Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 32 Oman Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
  • Table 33 Oman Clinical Trials Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 34 Oman Clinical Trials Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)
  • Table 35 Qatar Clinical Trials Market Estimates and Forecasts, by Phase, 2021 - 2033 (USD Million)
  • Table 36 Qatar Clinical Trials Market Estimates and Forecasts, by Study Design, 2021 - 2033 (USD Million)
  • Table 37 Qatar Clinical Trials Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
  • Table 38 Qatar Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
  • Table 39 Qatar Clinical Trials Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 40 Qatar Clinical Trials Market Estimates and Forecasts, by Sponsor, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Middle East Clinical Trials Market Segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information Procurement
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Dynamics
  • Fig. 9 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 PESTEL by SWOT Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Phase I Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Phase II Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Phase III Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Phase IV Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Interventional Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Observational Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Expanded Access Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Autoimmune/Inflammation Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Rheumatoid Arthritis Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Multiple Sclerosis Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Osteoarthritis Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Irritable Bowel Syndrome (IBS) Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Others Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Pain Management Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Chronic Pain Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Acute Pain Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Oncology Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Blood Cancer Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Solid Tumors Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Others Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 CNS Conditions Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Epilepsy Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Parkinson's Disease (PD) Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Huntington's Disease Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Stroke Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Traumatic Brain Injury (TBI) Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Amyotrophic Lateral Sclerosis (ALS) Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Muscle Regeneration Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Others Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Diabetes Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Obesity Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Cardiovascular Diseases Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Others Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Autoimmune/Inflammation Interventional Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Autoimmune/Inflammation Observational Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Autoimmune/Inflammation Expanded Access Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Pain Management Interventional Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Pain Management Observational Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Pain Management Expanded Access Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Oncology Interventional Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Oncology Observational Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Oncology Expanded Access Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 CNS Conditions Interventional Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 CNS Conditions Observational Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 CNS Conditions Expanded Access Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Diabetes Interventional Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Diabetes Observational Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Diabetes Expanded Access Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Obesity Interventional Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Obesity Observational Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Obesity Expanded Access Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Cardiovascular Diseases Interventional Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Cardiovascular Diseases Observational Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Cardiovascular Diseases Expanded Access Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Others Interventional Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Others Observational Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Others Expanded Access Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Protocol Designing Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Site Identification Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Patient Recruitment Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Laboratory Services Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Analytical Testing Services Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Clinical Trial Data Management Services Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Others Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Pharmaceutical & Biopharmaceutical Companies Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Medical Device Companies Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Others Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Regional Outlook, 2024 & 2033
  • Fig. 82 Middle East Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 South Africa Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Saudi Arabia Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 UAE Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Kuwait Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Oman Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Qatar Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!